XML 52 R19.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Impairment Testing | 12 Months Ended
--- | ---
Dec. 31, 2018
Notes to Consolidated Financial Statements [Abstract] |
Note 13 - Impairment Testing | Note 13 - Impairment Testing Impairment testing for intangible assets with an indefinite useful life Goodwill - The goodwill is not monitored for internal reporting purposes and, accordingly, it is allocated to the Company’s operating segments and not to the cash-generating units, the level of which is lower than the operating segment. The examination of impairment in the carrying amount of the goodwill is made accordingly. Trademarks - For impairment testing purpose, the trademarks with indefinite useful life were allocated to the cash-generating units, which represent the lowest level within the Company. The carrying amounts of intangible assets with an indefinite useful life are as follows:
| As at December 31
| 2018 | 2017
| $ millions | $ millions
Goodwill |  |
Phosphate Solutions | 127 | 140
Industrial Products | 92 | 93
Innovative Ag. Solutions | 71 | 73
Potash | 19 | 20
| 309 | 326
Trademarks |  |
Industrial Products, United States | 13 | 13
Phosphate Solutions, United States | 12 | 12
Industrial Products, Europe | 5 | 6
| 30 | 31
| 339 | 357
Note 13 - Impairment Testing (cont’d) Impairment testing for intangible assets with an indefinite useful life (cont’d) As a result of a structural change, which entered into effect on August 31, 2018, (see Note 5) the Company is operating through four business segments and consequently, goodwill has been reallocated to the new segments. The comparative Goodwill amounts have been restated to reflect this change. In preparation of the goodwill impairment testing, the after‑tax discount rate used for the calculation of the recoverable amount of the operating segments is 9.5% nominal. The long‑term growth rate is between 0% and 2%, in industries and markets in which the Company is engaged. The recoverable amount of the operating segments was determined based on their value in use, which is an internal valuation of the discounted future cash flows that will be generated from the continuing operation of the operating segments. The examinations determined that the carrying amount of the operating segments is lower than their recoverable amount and, accordingly, no impairment loss was recognized.

X
- References No definition available. + Details
Name: | icl_NotesToConsolidatedFinancialStatementsAbstract
Namespace Prefix: | icl_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the impairment of assets. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 36 -IssueDate 2018-01-01 -Section Disclosure -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=36&date=2018-03-01&anchor=sect_Disclosure&doctype=Standard -URIDate 2018-03-16 + Details
Name: | ifrs-full_DisclosureOfImpairmentOfAssetsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration